Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report 2024

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025 – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2025-2034

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025

Report Price : $4490.00 | Pages : 250 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Definition

Pharmaceutical contract development and manufacturing refers to a business that offers services for drug research and manufacturing within the pharmaceutical sector. Using CDMOs as a partner, pharmaceutical companies can outsource medication development and production. Full-service drug development and manufacturing outsourcing companies (CDMOs) can handle every stage of the process and work with clients who want to outsource specific steps in their workflow. Everything is based on the requirements of each client.

The main types of pharmaceutical contract development and manufacturing organizations (CMO) are contract manufacturing services and contract research services. Contract manufacturing services refer to the outsourcing of manufacturing processes or the production of goods to a third-party company, known as a contract manufacturer. The various research phases include preclinical, phase I, phase II, phase III, and phase IV. The different end-use sectors include big pharmaceutical companies, generic pharmaceutical companies, and small & medium-sized pharmaceutical companies.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segmentation

The pharmaceutical contract development and manufacturing organization (CMO) market covered in this report is segmented –

1) By Type: Contract Manufacturing Services, Contract Research Services

2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV

2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies

Subsegments:

1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management

2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size and growth rate 2025 to 2029: Graph

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size 2025 And Growth Rate

The pharmaceutical contract development and manufacturing organization (CMO) market size has grown strongly in recent years. It will grow from $174.33 billion in 2024 to $186.62 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to strong economic growth in emerging markets, rising healthcare expenditure, increase in pharmaceutical research and development (R&D) expenditure and increasing preference for outsourcing.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Growth Forecast

The pharmaceutical contract development and manufacturing organization (CMO) market size is expected to see strong growth in the next few years. It will grow to $260.83 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing government support, increase in healthcare access, increase in investments and increase in biopharmaceutical development will drive the market. Major trends in the forecast period include increased focus on sustainability, focus on integration of artificial intelligence and digitalization, innovative products with focus on resilience, increasing investments and strategic partnerships and collaborations among market players.

Book your 30 minutes free consultation with our research experts

Contact Us

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Driver: Rising Demand For Medicines Fuels Growth In Pharmaceutical Contract Development And Manufacturing Market

The growth of the pharmaceutical contract development and manufacturing market is driven by the increase in the demand for medicines across the globe. The high prevalence of diseases and the need for a longer lifespan increased the demand for medicines pushing the pharmaceutical companies to increase the production of existing drugs and raise the investment in their R&D to promote the development of new drugs. This impels pharmaceutical companies to collaborate with contract manufacturing organizations (CMOs) as a way to lower operational costs, thus, increasing the demand for pharmaceutical contract development and manufacturing market. According to Alkermes PLC., a biopharmaceutical company indicates that pharmaceutical contract manufacturing will emerge as a strategic option for many companies ranging from very large to smaller specialty pharma entities and this mostly will happen because the pharmaceutical companies are looking for cost-cutting.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Driver: Increasing Patent Expirations Are Anticipated To Fuel The Growth Of The Pharmaceutical Contract Development And Manufacturing Market

The increasing patent expiration is expected to propel the pharmaceutical contract development and manufacturing market. Patent expiration refers to the end of the legally protected exclusive rights granted to an inventor or patent holder to make, sell, or use an invention for a specified period of time. Pharmaceutical contract development and manufacturing aid in the swift development and production of generic drugs for market entry upon patent expiration. For instance, in 2023, according to the DrugPatentWatch, a US-based web-based service platform, a total of 37 drugs will face patent expirations, allowing generic entry into the market. Therefore, the increasing patent expiration is driving the pharmaceutical contract development and manufacturing market.

Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Major Players

Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals

Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trend: Strategic Mergers And Acquisitions Shape The Landscape Of The Pharmaceutical Contract Development And Manufacturing Market

The companies in the pharmaceutical contract development and manufacturing market are investing in acquiring and forming alliances with other companies in the market. The Pharmaceutical contract development and manufacturing companies are following the trend of merger and acquisition to expand their global market reach to meet client needs, increase their production capabilities while maintaining cost efficiencies, and get access to the latest technology and new services. The high levels of merger and acquisition activities result in the consolidation of the contract service providers. For instance, in July 2022, Pharma Nobis, a US-based provider of contract manufacturing and private label services, acquired Fagron’s U.S. contract manufacturing business for an undisclosed amount. Through this acquisition, Pharma Nobis is expected to offer contract manufacturing and private label services to American retailers and consumer healthcare corporations. 20% of the company will continue to be owned by Fagron.

Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trend: Pharmaceutical Contract Development And Manufacturing Firms Introduce Innovative Devpack Services To Enhance Industry Capabilities

Major companies operating in the pharmaceutical contract development and manufacturing market are providing new services such as the DevPack to enhance their service portfolios and meet the evolving needs of the industry. The DevPack is a service optimized across multiple partners to create a standardized dataset of development process steps. For instance, in May 2023, ASM Research Chemicals, a Germany-based company providing contract research and manufacturing services launched DevPack, a new development pack service intended for active pharmaceutical ingredients (APIs) manufacturing. The DevPack service, optimized across ten core partners, offers a standardized dataset for development processes. It aids in streamlining API research, development, and scale-up. Ideal for CMOs and pharmaceutical firms aiming for quick early-stage manufacturing route development for APIs, the service also supports analytical development and regulatory submissions.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Merger And Acquisition: Catalent Expands Expertise With Acquisition Of Metrics Contract Services

In August 2022, Catalent, Inc., a US-based provider of delivery technologies, development, and drug manufacturing, acquired Metrics Contract Services for $475 million. This acquisition is expected to improve Catalent's ability to work with highly potent chemicals while enhancing its expertise in integrated oral solid formulation research, production, and packaging to assist clients in streamlining and accelerating their processes. Metrics Contract Services is a US-based pharmaceutical contract development and manufacturing organization.

Regional Outlook For The Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical contract development and manufacturing organization (CMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

What Defines the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?

The pharmaceutical contract development and manufacturing market includes revenues earned by entities by providing drug development and manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Industry?

The pharmaceutical contract development and manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing market statistics, including pharmaceutical contract development and manufacturing industry global market size, regional shares, competitors' pharmaceutical contract development and manufacturing market share, detailed pharmaceutical contract development and manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing industry. This pharmaceutical contract development and manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $186.62 billion
Revenue Forecast In 2034 $260.83 billion
Growth Rate CAGR of 8.7% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies Subsegments: 1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Characteristics

    3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trends And Strategies

    4. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Growth Analysis And Strategic Analysis Framework

    5.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Growth Rate Analysis

    5.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Total Addressable Market (TAM)

    6. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segmentation

    6.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Contract Manufacturing Services

    Contract Research Services

    6.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Preclinical

    Phase I

    Phase II

    Phase III

    Phase IV

    6.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Big Pharmaceutical Companies

    Generic Pharmaceutical Companies

    Small And Medium-Sized Pharmaceutical Companies

    6.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Manufacturing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Active Pharmaceutical Ingredient (API) Manufacturing

    Formulation Development

    Finished Dosage Form Manufacturing

    Packaging Services

    Supply Chain Management

    6.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Research Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Preclinical Research Services

    Clinical Trial Management

    Regulatory Affairs Consulting

    Biostatistics And Data Management

    Analytical And Testing Services

    7. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Regional And Country Analysis

    7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    8.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    9.1. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    9.2. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    10.1. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    11.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    11.2. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    12.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    13.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    14.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    14.2. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    15.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    15.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    16.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    17.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    18.1. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    19.1. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    20.1. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    21.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    21.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    22.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    23.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    23.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    24.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    24.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    25.1. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    25.2. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    26.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    26.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    27.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    28.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    28.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    29.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    29.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape And Company Profiles

    30.1. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape

    30.2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Company Profiles

    30.2.1. Lonza Group Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Catalent Inc Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. WuXi AppTec Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Recipharm AB Overview, Products and Services, Strategy and Financial Analysis

    31. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Other Major And Innovative Companies

    31.1. Almac Group

    31.2. Aenova Group

    31.3. Baxter International Inc

    31.4. SGS Life Science Services SA

    31.5. Jubilant Pharmova Ltd

    31.6. Dishman Pharmaceuticals

    31.7. Kemwell Pvt. Ltd.

    31.8. Nipro Corp.

    31.9. CMIC Group

    31.10. Sawai Pharmaceutical Co., Ltd

    31.11. IDT Australia Limited

    31.12. Aurigene Pharmaceutical Services Limited

    31.13. Vetter Pharma International GMBH

    31.14. Consort Medical PLC

    31.15. Siegfried Holding AG

    32. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    34. Recent Developments In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    35. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market High Potential Countries, Segments and Strategies

    35.1 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2029 - Countries Offering Most New Opportunities

    35.2 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2029 - Segments Offering Most New Opportunities

    35.3 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Manufacturing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Research Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Lonza Group Financial Performance
  • Table 77: Catalent Inc Financial Performance
  • Table 78: WuXi AppTec Inc. Financial Performance
  • Table 79: Pfizer Inc Financial Performance
  • Table 80: Recipharm AB Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Manufacturing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Research Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Lonza Group Financial Performance
  • Figure 77: Catalent Inc Financial Performance
  • Figure 78: WuXi AppTec Inc. Financial Performance
  • Figure 79: Pfizer Inc Financial Performance
  • Figure 80: Recipharm AB Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the ophthalmology drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the pharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

Pharmaceutical Sterility Testing Global Market Report 2025 – By Sample (Sterile Drugs, Medical Devices, Biologics and Therapeutics), By Product Type (Instruments, Kits and Reagents, Services), By Type (In- house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End- User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Drugs Global Market Report 2025 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine And Therapeutic Nutrients, Minerals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter (OTC) Drugs, Prescription-Based Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Excipients Global Market Report 2025 – By Product (Inorganic Chemicals, Organic Chemicals, Other Products), By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities), By Type Of Formulation (Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Packaging Equipment Global Market Report 2025 – By Product (Primary Packaging Equipment, Secondary Packaging Equipment, Labelling And Sterilization Equipment), By Packaging Type (Liquids Packaging Equipment, Solid Packaging Equipment, Semi-Solid Packaging Equipment), By Equipment Type (Blenders, Granulators, Tablet Pressers, Tablet Coating Machine, Allied Machines), By Mode of Administration (Injectable Administration, Topical Administration, Oral Administration) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Processing Seals Global Market Report 2025 – By Type (O-rings, Gaskets, Lip seals, D seals, Other types (Diaphragms and X-rings)), By Material (Metals, PTFE, Silicone, Nitrile Rubber, EPDM, Other materials), By Application (Manufacturing Equipment, Agitators, Mixers, Reactors, Gear Boxes, Other applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Glass Packaging Global Market Report 2025 – By Product (Ampoules, Bottles , Vials, Syringes, Cartridges, Other Product Types), By Drug Type (Generic, Branded, Biologic), By Material (Type I, Type II, Type III), By Application (Oral, Injectable, Nasal, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Drug Delivery Global Market Report 2025 – By Route of Administration (Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes), By Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications), By End-User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Logistics Global Market Report 2025 – By Type (Cold Chain Logistics, Non-Cold Chain Logistics), By Component (Storage, Transportation, Monitoring Components), By Procedure (Picking, Storage, Retrieval Systems, Handling Systems), By Transportation (Sea Freight, Air Freight, Overland), By Application (Bio Pharma, Chemical Pharma, Specialty Pharma) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market?

Pharmaceutical contract development and manufacturing refers to a business that offers services for drug research and manufacturing within the pharmaceutical sector. Using CDMOs as a partner, pharmaceutical companies can outsource medication development and production. Full-service drug development and manufacturing outsourcing companies (CDMOs) can handle every stage of the process and work with clients who want to outsource specific steps in their workflow. Everything is based on the requirements of each client. For further insights on the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market, request a sample here

How will the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market drivers and restraints affect the market dynamics? What forces will shape the Pharmaceutical Contract Development And Manufacturing Organization (CMO) industry go

The Pharmaceutical Contract Development And Manufacturing Organization (CMO) market major growth driver - Rising Demand For Medicines Fuels Growth In Pharmaceutical Contract Development And Manufacturing Market. For further insights on the Pharmaceutical request a sample here

What is the forecast market size or the forecast market value of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market?

The Pharmaceutical Contract Development And Manufacturing Organization (CMO) market size has grown strongly in recent years. The pharmaceutical contract development and manufacturing organization (CMO) market size has grown strongly in recent years. It will grow from $174.33 billion in 2024 to $186.62 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to strong economic growth in emerging markets, rising healthcare expenditure, increase in pharmaceutical research and development (R&D) expenditure and increasing preference for outsourcing. The pharmaceutical contract development and manufacturing organization (CMO) market size is expected to see strong growth in the next few years. It will grow to $260.83 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing government support, increase in healthcare access, increase in investments and increase in biopharmaceutical development will drive the market. Major trends in the forecast period include increased focus on sustainability, focus on integration of artificial intelligence and digitalization, innovative products with focus on resilience, increasing investments and strategic partnerships and collaborations among market players. For further insights on the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market, request a sample here

How is the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market segmented?

The pharmaceutical contract development and manufacturing organization (CMO) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services For further insights on the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market, request a sample here

Which region has the largest share of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market? What are the other regions covered in the report?

North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market, request a sample here.

Who are the major players in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market?

Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals . For further insights on the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market, request a sample here.

What are the key trends in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market?

Major trends in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market include Strategic Mergers And Acquisitions Shape The Landscape Of The Pharmaceutical Contract Development And Manufacturing Market. For further insights on request a sample here.

What are the major opportunities in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market? What are the strategies for the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market?

For detailed insights on the major opportunities and strategies in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market, request a sample here.

How does the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market relate to the overall economy and other similar markets?

For detailed insights on Pharmaceutical Contract Development And Manufacturing Organization (CMO)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) industry?

For detailed insights on the mergers and acquisitions in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) industry, request a sample here.

What are the key dynamics influencing the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market growth? SWOT analysis of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market.

For detailed insights on the key dynamics influencing the Pharmaceutical Contract Development And Manufacturing Organization (CMO) market growth and SWOT analysis of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) industry, request a sample here.